Biotech CIMG Inc. Announces Entry into Computing Power Industry; Initial Contracts with Aggregate Value of Approximately $124 Million January 6, 2026
Biotech GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy January 5, 2026
Biotech MarathonLS and Pacer Announce Strategic Separation into Two Independent Organizations January 3, 2026
Biotech Last day of trading in shares with pre-emptive rights in connection with rights issue January 2, 2026
Biotech Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring December 31, 2025
Biotech CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596 December 29, 2025
Biotech Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study December 28, 2025